H ypertension, atherosclerosis, and mechanical injury exert common pathological effects on the vessel wall, such as vascular smooth muscle cell (VSMC) proliferation, monocyte/macrophage infiltration, endothelial dysfunction, and increased connective tissue deposition. 1 In addition, these vascular diseases have been shown to be associated with oxidative stress, and there is good evidence implicating angiotensin II in the oxidative stress associated with hypertension. 2, 3 However, we 4 and others 5 have reported increased oxidative stress in mineralocorticoid (deoxycorticosterone acetate [DOCA] ) hypertension, which is characterized by low angiotensin II levels. We also found that oxidative stress causes increased transcription of genes responsible for the early inflammatory response in the DOCA-salt hypertensive rat. 4 Moreover, a potentially significant consequence of oxidative stress is vascular smooth muscle cell proliferation 6 and NO inactivation, 7 which could play an important role in the vascular changes and causes of hypertension. However, the source of the oxidative (reactive oxygen species [ROS]) stress is not known. Early studies have identified endothelial xanthine oxidase and uncoupled endothelium NO synthase (eNOS) as possible sources of endothelium-dependent O 2 Ϫ production. 8 -10 It has since been established that smooth muscle cells and fibroblasts account for the majority of O 2 Ϫ produced by the vessel wall. It also has been known for years that cardiac tissues are rich in ROS, such as O 2 Ϫ , H 2 O 2 , and NO, and that virtually every cell in the vascular wall produces and is regulated by ROS. 11 Recent studies have focused on NADPH oxidase, which is found within the membrane of smooth muscle cells, as a critical source of ROS production within the vascular wall. 11 NADPH oxidase is one of the primary enzyme complexes involved in the antipathogenic actions of neutrophils and other phagocytic white cells; however, the vascular NADPH oxidase appears to be structurally and functionally different from the neutrophil NADPH oxidase. 11 Currently, all components of the NADPH oxidase have been found in endothelial cells, whereas only the p22phox subunit has been identified in VSMCs, and several studies have examined the mechanism of activation of this enzyme in the pathophysiology of hypertension. [11] [12] [13] From these studies, there have been 2 emerging common themes: (1) hypertension increases oxidative stress by increasing O 2 Ϫ production, and (2) NADPH oxidase in vascular cells and myocytes may play an important role in this response.
We 4 and others 5 have shown that DOCA-salt rats have increased aortic O 2 Ϫ production and that treatment with antioxidants normalizes O 2 Ϫ production and attenuates hypertension. 4 In the present study, we tested whether NADPH oxidase, xanthine oxidase, or uncoupled eNOS is responsible for the increased O 2 Ϫ production observed in the DOCA-salt rat. We used apocynin, allopurinol, and N-nitro-L-arginine (L-NNA) to inhibit NADPH oxidase, xanthine oxidase, and eNOS, respectively. Apocynin, a methoxy-substituted catechol from the medicinal herb Picroria kurroa, has been used in primitive cultures for the treatment of inflammatory diseases. 14 It has also been shown to impede the assembly of the p47phox and p67phox subunit within the membrane NADPH oxidase complex. 14 Allopurinol is an analog of hypoxanthine and has been shown to be a potent inhibitor of xanthine oxidase in human and animal models. The third potential source of vascular ROS production is eNOS, which requires tetrahydrobiopterin to transfer electrons to L-arginine to form NO. In the absence of L-arginine or tetrahydrobiopterin, eNOS can produce O 2 Ϫ . In view of these observations, we hypothesized that the treatment of DOCA-salt rat aorta with the NADPH oxidase inhibitor apocynin would decrease aortic O 2 Ϫ production. In addition, we hypothesized that long-term treatment of DOCA-salt rats with apocynin would attenuate the increase in systolic blood pressure.
Methods
Experiments were conducted in male Sprague-Dawley rats (Harlan, Indianapolis, Ind), and all procedures were approved by the institutional animal care and use committee. Rats were anesthetized with an intramuscular injection of ketamine (100 mg/kg)/xylazine (20 mg/ kg) (The Butler Company), and a Silastic (Dow Corning) sheet containing DOCA-salt (Sigma; 200 mg/kg body weight) was inserted subcutaneously via midscapular incision. Right uninephrectomy was performed via flank incision. Rats treated with DOCA-salt received 1% NaCl and 0.1% KCl in drinking water for 28 days, and 5 DOCA-salt rats also received apocynin (1.5 mmol/L), which was added to their water to block NADPH oxidase. Sham-operated rats underwent uninephrectomy without implantation of the Silastic/ DOCA sheet and were given tap water. Twenty-eight days after implantation, systolic blood pressure was measured according to the tail-cuff method, and rats were anesthetized with ketamine/xylazine. The aorta was carefully removed, cleaned of excess fat and adventitia, and placed in PSS composed of (in mmol/L) NaCl 130, KCl 4.7, KH 2 PO 4 1.18, MgSO 4 · 7H 2 O 1.17, NaHCO 3 14.9, dextrose 5.5, EDTA 0.26, and CaCl 2 1.6. Aorta was cut into 2-to 3-mm rings and treated for 1 hour with either 10
Ϫ4 mol/L apocynin. These concentrations were selected based on previously reported inhibitory activity. Some rings were also de-endothelialized and treated as previously stated. Lucigenin chemiluminescence with 5 mol/L lucigenin 15, 16 was used to measure O 2 Ϫ production in these ring segments. Details of this assay have been published previously. 17, 18 Reverse Transcriptase-Polymerase Chain Reaction RNA was extracted from aorta using a preparative kit (Qiagen). RNA (1 g) was used for first-strand cDNA synthesis with AMV reverse transcriptase (RT) and oligo(dT) as primer. Polymerase chain reaction (PCR) amplifications were carried out on a portion of the cDNA produced using specific oligonucleotide primers for p22phox (5Ј-GTGGACAGAAGTACCTGA-3Ј and 3Ј-GGAGCAACAC-CTTGGAA-5Ј) and cyclophilin. Reactions were performed using a PE Applied Biosystems GeneAmp thermal cycler and Thermus aquaticus DNA polymerase (Taq). The reaction contained 5 pmol/L concentration of each oligonucleotide primer, 200 mol/L dNTP, 0.2 U Taq, 1.5 mol/L MgCl, and 1 Ci [ 32 P]dCTP in the manufacturer's buffer. Optimum annealing temperature, cycle number, and template dilution factor were determined for each amplicon before experimentation. The cDNA was resolved on an 8% polyacrylamide gel, and the amount of DNA present was identified by PhosphorImager analysis (Bio-Rad) and quantified by Multi-analyst software.
Statistical Analysis
Data are presented as meanϮSEM. Statistically significant differences among groups were tested by ANOVA, Tukey's multiple range test, or t test as appropriate. A value of PϽ0.05 was considered statistically significant.
An expanded Methods section can be found in an online data supplement available at http://www.hypertensionaha.org.
Results
Systolic blood pressure increased significantly in DOCA-salt rats compared with sham-operated rats after 28 days of treatment (196Ϯ4 versus 111Ϯ2 mm Hg, respectively; nϭ5 in all groups) ( Figure 1A ). In addition, O 2 Ϫ counts were significantly higher in aortic segments from DOCA-salt rats compared with those from sham-operated rats (6591Ϯ353 in DOCA-salt rats versus 2513Ϯ158 counts · mg Ϫ1 · min Ϫ1 in sham-operated rats; nϭ5 in all groups) ( Figure 1B) .
Role of NADPH Oxidase in O 2
؊ Production O 2 Ϫ counts in aortic rings from DOCA-salt rats averaged 6591Ϯ353 counts · mg Ϫ1 · min Ϫ1 , and treatment for 1 hour with either allopurinol or L-NNA had no significant effect (6739Ϯ343 versus 6350Ϯ420 counts · mg Ϫ1 · min Ϫ1 , respectively; nϭ5 in all groups, PϽ0.05). However, treatment with the NADPH oxidase inhibitor apocynin decreased O 2 Ϫ counts significantly (from 6591Ϯ353 counts · mg Ϫ1 · min Ϫ1 in DOCA-salt rats to 4409Ϯ347 counts · mg Ϫ1 · min Ϫ1 ; nϭ5 in all groups, PϽ0.05) (Figure 2) .
To examine further the role of NADPH oxidase, O 2 Ϫ counts were assessed in de-endothelialized aortic rings. There was no significant difference in O 2 Ϫ production in sham de-endothelialized vessels compared with sham intact vessels (2237Ϯ319 versus 2513Ϯ158 counts · mg Ϫ1 · min Ϫ1 , respectively; nϭ5 in all groups). There also was no significant difference in de-endothelialized versus intact DOCA-salt rat aorta (6394Ϯ455 versus 6591Ϯ353 counts · mg Ϫ1 · min Ϫ1 , respectively; nϭ5 in all groups) (Figure 3 ).
In agreement with the effect of apocynin to inhibit NADPH oxidase O 2 Ϫ production in vitro, long-term treatment of DOCA-salt rats with 1.5 mmol/L apocynin significantly decreased systolic blood pressure compared with that of rats treated with DOCA-salt alone (149Ϯ4 versus 193Ϯ4 mm Hg, respectively; nϭ5 in all groups, PϽ0.001). Treatment of DOCA-salt rats with apocynin for 28 days also decreased O 2 Ϫ production significantly in aortic rings compared with that of rats treated with DOCA-salt alone (5433Ϯ472 versus 6591Ϯ352 counts · mg Ϫ1 · min Ϫ1 , respectively; nϭ5 in all groups, PϽ0.05) ( Figure 4B ).
p22phox mRNA Expression
RT-PCR analyses of aortic p22phox mRNA in shamoperated, DOCA-salt, and DOCA-salt plus apocynin-treated rats are shown in Figure 5 . The aorta from the DOCA-salt rats had significantly greater mRNA for p22phox compared with that from the sham-operated animals (0.628Ϯ0.085 versus 0.391Ϯ0.035 arbitrary PhosphorImager units normalized to cyclophilin, respectively; nϭ5 in all groups, PϽ0.05), and treatment of the DOCA-salt rats with apocynin did not reduce the expression of p22phox mRNA (0.628Ϯ0.085 versus 0.493Ϯ0.095 arbitrary PhosphorImager units normalized to cyclophilin for DOCA-salt versus DOCA-salt plus apocynin; PϽ0.05) ( Figure 5 ).
Discussion
These results provide the first evidence that NADPH oxidase is involved in aortic O 2 Ϫ production in the DOCA-salt rat. Furthermore, we found that inhibition of NADPH oxidase with apocynin attenuates systolic blood pressure, which may be due in part to increased NO bioavailability. DOCA-salt rats also exhibited an increase in mRNA levels of the NADPH oxidase subunit p22phox, and interestingly, treat- 
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ment of DOCA-salt animals with apocynin caused a slight, but not statistically significant, decrease in p22phox mRNA levels, rather than a compensatory increase, as expected in the face of blockade with apocynin. NADPH oxidase is expressed in endothelial cells, 19 adventitial fibroblasts, 20 VSMCs, 2 and infiltrating monocytes and macrophages. 21 Although the exact location of NADPH oxidase was not localized in the present study, several previous studies strongly suggest NADPH oxidase is found mainly in VSMCs and is responsible for the formation of ROS within the vasculature. For example, Zalba et al 22 reported that removal of the adventitia from the aorta of spontaneously hypertensive rats (SHR) does not significantly change ROS production. Furthermore, the same authors showed that de-endothelialization of SHR aorta did not affect NADPH oxidase activity. In addition, it has been reported that hypertension causes aortic monocyte/macrophage infiltration, 21 thus implicating a role for leukocyte infiltration in ROS production within the aorta. In contrast to this observation, we found through immunofluorescence analysis that aorta from DOCA-salt rats exhibited no monocyte/macrophage infiltration (R.A.B. and R.C.W., unpublished observations, 2000). Furthermore, de-endothelialization did not affect ROS production, suggesting that vascular smooth muscle cells or fibroblasts were the source.
It is not presently clear which factors are responsible for NADPH oxidase activity. However, it is interesting that SHR exhibit no significant difference in NADPH oxidase activity when young but develop a difference by adulthood, 22 suggesting that long-term hypertension may be necessary for the activation of NADPH oxidase. Alternatively, nonhemodynamic factors, such as tissue hormones, stretch, or cytokines, may be responsible for enhancing NADPH oxidase activity. Recent studies in vitro raise the possibility that stretch of the vasculature could enhance O 2 Ϫ and H 2 O 2 production by NADPH oxidase during a relatively short period of time. 23, 24 Therefore, it is conceivable that direct stretch of vasculature may have these same effects.
Previously, workers at our laboratory and others found that DOCA-salt hypertension markedly increased O 2 Ϫ production, which in turn diminished NO-dependent relaxation and hypertension. 4, 5 Furthermore, treatment of DOCA-salt rats with the antioxidants pyrrolidinedithiocarbamate and Tempol decreased systolic blood pressure. 4 The present study adds to these findings by showing that NADPH oxidase plays an important role in vascular O 2 Ϫ production in the DOCA-salt rat. On the other hand, we did not find that inhibition of NOS with L-NNA significantly affected O 2 Ϫ production in aortic rings from DOCA-salt rats, suggesting, therefore, that uncoupled eNOS plays little, if any, role in O 2 Ϫ production in the DOCA-salt rat model. This is further supported by our observation that de-endothelialization of aortic rings from DOCA-salt rats did not affect O 2 Ϫ production. The reason for these different findings is not known, but other studies have also reported that oxypurinol had no significant effect on O 2 Ϫ production in mechanically stretched human cultured aortic endothelial cells. 23, 24 In the present study, we show that O 2 Ϫ production in aortic segments from hypertensive and normotensive rats was not blocked by the xanthine oxidase inhibitor allopurinol. This does not support a major role for xanthine oxidase in O 2 Ϫ production in DOCA-salt-induced hypertension. In contrast, we found that treatment of aortic rings from DOCA-salt rats with the NADPH oxidase inhibitor apocynin results in a significant decrease in O 2 Ϫ production. This result is consistent with the results of Hishikawa et al, 24 who also demonstrated that inhibition of NADPH oxidase with diphenyleneiodonium chloride decreased O 2 Ϫ production in aortic smooth muscle cells.
DOCA-salt hypertension is associated with markedly depressed plasma renin activity and reduced circulating angiotensin II. However, it is possible that angiotensin II produced in the vascular wall stimulates O 2 Ϫ production via activation of NADPH oxidase. Low-dose administration of angiotensin II has been reported to stimulate increased NADPH oxidase activity without raising blood pressure, whereas norepinephrine-induced hypertension does not stimulate NADPH oxidase activity. 2 Moreover, it has been shown that in vitro perfusion of vessels at high pressure results in production of angiotensin II by the local renin-angiotensin system. 25 Thus, local angiotensin II produced within the vessel wall theoretically could contribute to increased O 2 Ϫ production observed in the DOCA-salt rat. Recent studies, however, have shown that the treatment of DOCA-salt rats with the angiotensin II inhibitor losartan does not significantly alter blood pressure, 5 suggesting that locally produced angiotensin II does not contribute to elevated peripheral vascular resistance and calling into question its role in O 2 Ϫ generation in this model as well.
In summary, we report that NADPH oxidase activity is increased in the aortic wall of the DOCA-salt rat and that this increase is associated with elevated O 2 Ϫ production. Further- Figure 5 . Quantification of aortic p22phox mRNA by RT-PCR analysis. DOCA-salt rats had significantly increased amounts of p22phox mRNA levels compared with those of sham-operated rats. Treatment of DOCA-salt rats with the NADPH oxidase inhibitor apocynin (APO) resulted in a decrease in p22phox mRNA levels compared with DOCA-salt, but the difference was not statistically significant. Results are expressed as meanϮSEM (nϭ5 rats per group). *PϽ0.05 vs sham.
